期刊文献+

结直肠癌术后D-二聚体水平对癌症复发和不良预后的影响及预测价值 被引量:3

Influence and predictive value of D-dimer level on cancer recurrence and poor prognosis after colorectal cancer surgery
在线阅读 下载PDF
导出
摘要 目的检测结直肠癌术后D-二聚体水平,分析其对癌症复发和不良预后的影响及预测价值。方法收集2016年1月至2018年4月在南阳市第二人民医院接受完全治愈性切除结直肠癌病人132例,男75例,女57例,年龄(67.3±8.4)岁。根据术后1周D-二聚体平均值3.1 mg/L,将病人分为D-二聚体低水平组(<3.1 mg/L)和D-二聚体高水平组(≥3.1 mg/L),比较两组间的临床病理特征、术后1、3年疾病无进展生存率和生存率。分析影响术后1、3年疾病无进展生存率和生存率的危险因素。结果D-二聚体高水平组与低水平组间TNM分期、T分期、N分期、神经侵犯、脉管浸润和肿瘤长径比较差异有统计学意义(P<0.05)。D-二聚体高水平组术后3年疾病无进展生存率和生存率分别为62.2%(46/74)、70.3%(52/74)均低于D-二聚体低水平组79.3%(46/58)、86.2%(50/58)(χ^(2)=4.35、4.63,P=0.037、0.032)。D-二聚体为影响术后3年疾病无进展生存率和生存率的独立危险因素(P<0.05)。D-二聚体预测病人术后3年复发的曲线下面积为0.82[95%CI:(0.78,0.86)],预测病人术后3年不良预后的曲线下面积为0.73[95%CI:(0.71,0.77)],D-二聚体对病人术后3年疾病复发的预测价值高于对不良预后的预测价值(Z=5.30,P=0.006)。结论结直肠癌病人接受完全治愈性切除术后1周D-二聚体水平为病人术后3年疾病复发和不良预后的独立危险因素,对疾病复发具有较高的预测价值。 Objective To measure the level of D-dimer after colorectal cancer surgery and analyze its impact and predictive value on cancer recurrence and poor prognosis.Methods A total of 132 patients,75 males and 57 females,aged 67.3±8.4 years old,who underwent complete curative resection at the Nanyang Second General Hospital from January 2016 to April 2018 were enrolled.Based on the mean value of D-dimer at 1 week postoperatively,patients were divided into a low-level D-dimer group(<9.6 mg/L)and a high-level D-dimer group(≥9.6 mg/L).The clinicopathological characteristics,disease progression-free survival and survival rates at 1 and 3 years postoperatively were compared between the two groups.Risk factors affecting disease progression-free survival and survival rate at 1 and 3 years postoperatively were analyzed.Results The differences in TNM stage,T stage,N stage,nerve invasion,vascular infiltration and tumor length diameter between the high-level D-dimer group and the low-level group were statistically significant(P<0.05).The 3-year disease progression-free survival rate and survival rate in the high-level D-dimer group were 62.2%(46/74)and 70.3%(52/74),respectively,which were lower than those in the low-level D-dimer group,79.3%(46/58)and 86.2%(50/58)(χ^(2)=4.35,4.63,P=0.037,0.032).D-dimer was an independent risk factor affecting the disease progression-free survival rate and survival rate after 3 years postoperatively(P<0.05).The area under the curve for D-dimer to predict patient recurrence at 3 years postoperatively was 0.82[95%CI:(0.78,0.86)],the area under the curve for predicting poor prognosis for patients at 3 years postoperatively was 0.73[95%CI:(0.71,0.77)],and the predictive value of D-dimer for disease recurrence at 3 years postoperatively was higher than the predictive value for poor prognosis in patients(Z=5.30,P=0.006).Conclusion The D-dimer level at 1 week after complete curative resection in patients with colorectal cancer was an independent risk factor for disease recurrence and poor prognosis at 3 years after surgery and had a high predictive value for disease recurrence.
作者 宋宗工 SONG Zonggong(Minimally Invasive Surgery,Nanyang Second General Hospital,Nanyang,Henan 473000,China)
出处 《安徽医药》 CAS 2023年第9期1865-1869,共5页 Anhui Medical and Pharmaceutical Journal
关键词 结直肠肿瘤 D-二聚体 复发 生存率 Colorectal neoplasms D-dimer Recurrence Survival rate
  • 相关文献

参考文献1

二级参考文献27

  • 1陈芳,宁琴,孙汉英,苏凯,严伟明,习东,罗小平,刘文励.恶性肿瘤组织中人纤维介素的表达及作用[J].华中科技大学学报(医学版),2006,35(4):444-448. 被引量:8
  • 2Farge D,Durant C,Villiers S. Lessons from French National Guidelines on the treatment of venous thrombosis and central venous catheter thrombosis in cancer patients[J].Thrombosis Research,2010,(Suppl 2):S108-S116.
  • 3VM Konala,J Sprandio,DH Henry. A case of lung cancer and hypercoagulability,complicated by suspected heparininduced thrombocytopenia[J].Community Oncology,2011,(05):233-236.
  • 4Gramling MW,Church FC. Plasminogen activator inhibitor-1 is an aggregate response factor with pleiotropic effects on cell signaling in vascular disease and the tumor microenvironment[J].Thrombosis Research,2010,(05):377-381.
  • 5Bajou K,Peng H,Laug WE. Plasminogen activator inhibitor-1 protects endothelial cells from FasL-mediated apoptosis[J].Cancer Cell,2008,(04):324-334.doi:10.1016/j.ccr.2008.08.012.
  • 6Balsara RD,Ploplis VA. Plasminogen activator inhibitor1:the double-edged sword in apoptosis[J].Thrombosis and Haemostasis,2008,(06):1029-1036.
  • 7Su K,Chen F,Yan WM. Fibrinogen-like protein 2/fibroleukin prothrombinase contributes to tumor hypercoagulability via IL-2 and IFN-gamma[J].World Journal of Gastroenterology,2008,(39):5980-5989.doi:10.3748/wjg.14.5980.
  • 8Asanuma K,Wakabayashi H,Okamoto T. The thrombin inhibitor,argatroban,inhibits breast cancer metastasis to bone[J].Breast Cancer,2012.
  • 9Poon RT,Lau CP,Ho JW. Tissue factor expression correlates with tumor angiogenesis and invasiveness in human hepatocellular carcinoma[J].Clinical Cancer Research,2003,(14):5339-5345.
  • 10Wang X,Wang M,Amarzguioui M. Downregulation of tissue factor by RNA interference in human melanoma LOX-L cells reduces pulmonary metastasis in nude mice[J].International Journal of Cancer,2004,(06):994-1002.

共引文献38

同被引文献23

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部